Disease Management · Chronic Care · Health Policy
Disease Management Protocols
Chronic Disease
Federal Policy
Chronic disease is a central challenge for the U.S. health care system. The Centers for Disease Control and Prevention (CDC) reports that 6 in 10 U.S. adults have a chronic disease and 4 in 10 have two or more. Conditions such as diabetes and congestive heart failure call for ongoing, coordinated care rather than one-off treatment.
Disease management protocols are structured, evidence-based frameworks that support consistent care, coordination across the care team, and ongoing monitoring. This article looks at how these protocols relate to federal priorities set by the U.S. Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS), as the federal government sharpens its focus on chronic disease.
Federal Focus on Chronic Disease and Care Management
HHS has identified chronic disease as a core national health challenge in its stated priorities. Its emphasis includes risk reduction, early intervention, and coordinated long-term management, with attention to populations that face access barriers.
HHS also points to the value of patient education, better access to preventive services, and sustainable care models that stay consistent across settings. These priorities form the policy context in which disease management protocols have become more relevant.
Federal Models Shaping Chronic Disease Care
CMS continues to test payment and care-delivery models focused on chronic conditions through its Innovation Center. One recent example is the MAHA ELEVATE Model.
MAHA ELEVATE Model at a Glance
What it is: A voluntary CMS Innovation Center model announced in late 2025.
Focus: Whole-person, evidence-based lifestyle and prevention interventions for Original Medicare beneficiaries, such as nutrition and physical activity.
Funding: Approximately $100 million for up to 30 three-year cooperative agreements.
Timeline: A notice of funding opportunity in 2026, with a first cohort planned to begin September 1, 2026.
Note: CMS describes these interventions as intended to support, not replace, the medical care patients already receive.
CMS also tests models that expand technology-supported care for common chronic conditions. These models do not mandate specific clinical workflows, but they reinforce the same goal disease management protocols serve: applying structured, consistent approaches that support better health and help reduce the risk of disease progression.
What Disease Management Protocols Support at the Policy Level
Disease management protocols give practices a structured way to turn federal health priorities into day-to-day care. Federal guidance does not prescribe specific protocols, but several recurring themes map closely to how protocols are used.
| Federal Priority | How Disease Management Protocols Support It |
|---|---|
| Evidence-based care | Protocols keep clinical interventions grounded in established guidelines and consistent across different care settings. |
| Coordinated care across providers | Protocols define roles and responsibilities across the care team, supporting communication and continuity for patients with complex needs. |
| Consistent care with room for individual needs | Protocols standardize the core approach while allowing flexibility to meet each patient’s circumstances and reduce unwarranted variation. |
The Role of Digital Health and Remote Monitoring
Federal health policy recognizes the growing role of digital health in chronic disease care. Technologies such as Remote Patient Monitoring (RPM) are referenced as ways to improve visibility into patient status and support timely follow-up.
When built into disease management protocols and broader care management programs such as Chronic Care Management (CCM), RPM can help care teams review clinical trends, support medication adherence, and identify changes earlier, which is valuable for conditions such as congestive heart failure where noticing changes early matters. RPM is for monitoring only and does not replace in-person clinical evaluation or emergency care.
Key Point
Federal guidance is consistent on one point: digital health technologies and structured programs should support, not replace, clinical judgment and established care relationships.
Cost, Quality, and Outcome Considerations
Federal discussions on chronic disease often weigh quality against sustainability. Disease management protocols support this balance by standardizing workflows that reduce unnecessary variation and support consistent care, which can contribute to potential savings over time.
By supporting coordinated care, consistent monitoring, and patient engagement, protocols are designed to improve care delivery in ways that may improve outcomes and reduce avoidable utilization. These aims match broader federal goals to improve quality and strengthen health system performance.
How DrKumo Supports Disease Management Protocols
DrKumo provides secure, HIPAA-compliant digital health technology that helps organizations put structured, coordinated chronic-care processes into practice. Through RPM, DrKumo supports consistent data collection from medical devices as defined by the FDA, so care teams can review trends and follow up on changes in a patient’s status.
The technology supports care management workflows, communication across the care team, and adherence to the provider-led disease management protocols a practice already uses. For organizations building toward a comprehensive remote patient monitoring program, DrKumo supplies the technology while protocol design and clinical decisions remain with licensed providers.
DrKumo is not a clinical entity and does not provide clinical services. Providers retain full clinical responsibility for patient care decisions.
Key Takeaways
Federal priorities from HHS and CMS emphasize structured, coordinated chronic-disease care. Disease management protocols support these priorities through evidence-based, consistent workflows, care-team coordination, and patient engagement.
Federal models such as the CMS MAHA ELEVATE Model reflect growing attention to prevention and whole-person care for chronic conditions, while emphasizing that new approaches support existing medical care.
Paired with technology such as RPM, protocols can help care teams review trends and follow up in a timely way. DrKumo provides the technology and is not a clinical entity; licensed providers retain responsibility for all clinical decisions.
Coordinated Chronic Care Starts Here
Put disease management protocols into practice with secure technology.
To learn how DrKumo can support disease management protocols with HIPAA-compliant remote patient monitoring and coordinated care workflows, contact us today. Our team is ready to support your efforts to deliver high-quality care.
Frequently Asked Questions
What are disease management protocols?
How do disease management protocols relate to federal health priorities?
What is the MAHA ELEVATE Model?
How does remote patient monitoring fit into disease management?
Do disease management protocols replace clinical judgment?
References
Centers for Medicare & Medicaid Services. MAHA ELEVATE Model. CMS.gov.
Centers for Medicare & Medicaid Services. CMS Innovation Center Overview. CMS.gov.
Centers for Disease Control and Prevention. Fast Facts: Health and Economic Costs of Chronic Conditions. CDC.gov.
Disclaimer: This content is for general informational and educational purposes only and does not constitute medical, clinical, legal, regulatory, or policy advice. References to federal agencies, programs, or strategies are informational and do not constitute or imply endorsement by any government entity. Healthcare practices, regulatory requirements, and clinical guidelines vary by jurisdiction and may change over time. Organizations should consult licensed healthcare professionals, compliance experts, and official government sources before implementing disease management protocols, programs, or related digital health solutions.
